Dlco Or Nt-Probnp As A Screening Tool For Pah In Subjects With COPD

被引：0
|
作者：
Vanderpool, R. R. [1 ]
Risbano, M. G. [1 ]
Leo, N. [2 ]
Kessinger, C. [2 ]
Kingsley, L. [1 ]
Zhang, Y. [1 ]
Bachman, T. N. [1 ]
Simon, M. A. [1 ]
Gladwin, M. T. [3 ]
Sciurba, F. C. [2 ]
Morris, A. M. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3981
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
    Hammerer-Lercher, Angelika
    Griesmacher, Andrea
    Poelzl, Gerhard
    Brinskelle-Schmal, Natascha
    Mair, Johannes
    Frick, Matthias
    Hawa, Gerhard
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (10) : 1305 - 1308
  • [32] NT-proBNP对评估COPD急性加重风险的意义
    夏敬文
    董樑
    龚益
    朱柠
    陈小东
    临床肺科杂志, 2014, 19 (01) : 94 - 96
  • [33] Crp And Nt-Probnp In Combination Are Promising Blood Tests To Diagnose COPD Exacerbations
    Chen, Y. -W. R.
    Tam, S.
    Chen, V.
    Hollander, Z.
    Ng, R. T.
    McManus, B. M.
    FitzGerald, J. M.
    Lazarus, S. C.
    Woodruff, P. G.
    Connett, J. E.
    Criner, G. J.
    Albert, R.
    Han, M. K.
    Man, P.
    Sin, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] NT-PROBNP IN CASES WITH METABOLIC SYNDROME AND THE RELATIONSHIP BETWEEN NT-PROBNP AND CLINICAL AND LABORATORY PARAMETERS
    Bas, M.
    Yizdiz, A.
    Sezen, Y.
    Gur, M.
    Polat, M.
    Demirbag, R.
    Yilmaz, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 132 - 132
  • [35] Placental Expression of proBNP/NT-proBNP and Plasma Levels of NT-proBNP in Early- and Late-Onset Preeclampsia
    Junus, Katja
    Wikstrom, Anna-Karin
    Larsson, Anders
    Olovsson, Matts
    AMERICAN JOURNAL OF HYPERTENSION, 2014, 27 (09) : 1225 - 1230
  • [36] Utility of NT-proBNP as screening for cardiovascular disease in health checkup examination
    Kitagawa, F.
    Ishii, J.
    Kuno, A.
    Nakashima, A.
    Naruse, H.
    Matsui, S.
    Ishikawa, T.
    Tanaka, I.
    Hishida, H.
    Ozaki, Y.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A79 - A79
  • [37] NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension
    Souza, Rogerio
    Jardim, Carlos
    Julio Cesar Fernandes, Caio
    Silveira Lapa, Monica
    Rabelo, Rogerio
    Humbert, Marc
    RESPIRATORY MEDICINE, 2007, 101 (01) : 69 - 75
  • [38] NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort
    Labaki, Wassim W.
    Xia, Meng
    Murray, Susan
    Curtis, Jeffrey L.
    Barr, R. Graham
    Bhatt, Surya P.
    Bleecker, Eugene R.
    Hansel, Nadia N.
    Cooper, Christopher B.
    Dransfield, Mark T.
    Wells, J. Michael
    Hoffman, Eric A.
    Kanner, Richard E.
    Paine, Robert, III
    Ortega, Victor E.
    Peters, Stephen P.
    Krishnan, Jerry A.
    Bowler, Russell P.
    Couper, David J.
    Woodruff, Prescott G.
    Martinez, Fernando J.
    Martinez, Carlos H.
    Han, MeiLan K.
    RESPIRATORY MEDICINE, 2018, 140 : 87 - 93
  • [39] Echocardiographic Screening for Pulmonary Hypertension in Stable COPD Out-Patients and NT-proBNP as a Rule-Out Test
    Andersen, Charlotte U.
    Mellemkjaer, Soren
    Nielsen-Kudsk, Jens E.
    Sonderskov, Lene D.
    Laursen, Britt E.
    Simonsen, Ulf
    Hilberg, Ole
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (05) : 505 - 512
  • [40] Predictors of NT-proBNP response in primary care patients with heart failure and NT-proBNP guided therapy
    Erntell, H.
    Swedberg, K.
    Jorgensen, L.
    Dahlstrom, U.
    Persson, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S31 - S31
12345